COMMUNITY-ACQUIRED PNEUMONIA
Clinical trials for COMMUNITY-ACQUIRED PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new COMMUNITY-ACQUIRED PNEUMONIA trials appear
Sign up with your email to follow new studies for COMMUNITY-ACQUIRED PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep viral pneumonia patients out of hospital
Disease control TerminatedThis study tested whether adding the drug silmitasertib to standard care helps adults with viral pneumonia (from COVID-19 or flu) avoid hospitalization or death. About 45 outpatients with mild-to-moderate pneumonia took part. The trial was stopped early, so results are limited.
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA
Phase: PHASE2 • Sponsor: Senhwa Biosciences, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Scientists investigate immune cell behavior in Life-Threatening pneumonia
Knowledge-focused TerminatedThis study looked at how certain immune cells behave in people with severe pneumonia, including those who develop acute respiratory distress syndrome (ARDS). Researchers compared blood and lung fluid samples from 100 ICU patients with pneumonia to 50 healthy controls. The goal wa…
Matched conditions: COMMUNITY-ACQUIRED PNEUMONIA
Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:15 UTC